10 20 30 40 50 60 70 80 1JN9 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER HYDROLASE 23-JUL-01 1JN9
TITLE STRUCTURE OF PUTATIVE ASPARAGINASE ENCODED BY ESCHERICHIA COLI YBIK TITLE 2 GENE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE L-ASPARAGINASE; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: N-TERMINUS (RESIDUES 2-178); COMPND 5 SYNONYM: L-ASPARAGINE AMIDOHYDROLASE; COMPND 6 EC: 3.5.1.1; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: PUTATIVE L-ASPARAGINASE; COMPND 10 CHAIN: B, D; COMPND 11 FRAGMENT: C-TERMINUS (RESIDUES 179-321); COMPND 12 SYNONYM: L-ASPARAGINE AMIDOHYDROLASE; COMPND 13 EC: 3.5.1.1; COMPND 14 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: JM109; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET11D; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 11 ORGANISM_TAXID: 562; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 14 EXPRESSION_SYSTEM_STRAIN: JM109; SOURCE 15 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 16 EXPRESSION_SYSTEM_PLASMID: PET11D
KEYWDS NTN HYDROLASE, ASPARAGINASE, AUTOPROTEOLYSIS, HYDROLASE
EXPDTA X-RAY DIFFRACTION
AUTHOR D.BOREK,M.JASKOLSKI
REVDAT 3 13-JUL-11 1JN9 1 VERSN REVDAT 2 01-APR-08 1JN9 1 JRNL VERSN REMARK REVDAT 1 09-SEP-03 1JN9 0
JRNL AUTH K.MICHALSKA,D.BOREK,A.HERNANDEZ-SANTOYO,M.JASKOLSKI JRNL TITL CRYSTAL PACKING OF PLANT-TYPE L-ASPARAGINASE FROM JRNL TITL 2 ESCHERICHIA COLI. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 64 309 2008 JRNL REFN ISSN 0907-4449 JRNL PMID 18323626 JRNL DOI 10.1107/S0907444907068072
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.BOREK,M.JASKOLSKI REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY CRYSTALLOGRAPHIC STUDIES OF REMARK 1 TITL 2 A NEW L-ASPARAGINASE ENCODED BY THE ESCHERICHIA COLI GENOME REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 56 1505 2000 REMARK 1 REFN ISSN 0907-4449 REMARK 1 DOI 10.1107/S0907444900010076 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.A.BRANNIGAN,G.DODSON,H.J.DUGGLEBY,P.C.MOODY,J.L.SMITH, REMARK 1 AUTH 2 D.R.TOMCHICK,A.G.MURZIN REMARK 1 TITL A PROTEIN CATALYTIC FRAMEWORK WITH AN N-TERMINAL NUCLEOPHILE REMARK 1 TITL 2 IS CAPABLE OF SELF-ACTIVATION REMARK 1 REF NATURE V. 378 416 1995 REMARK 1 REFN ISSN 0028-0836 REMARK 1 DOI 10.1038/378416A0 REMARK 1 REFERENCE 3 REMARK 1 AUTH J.XUAN,A.L.TARENTINO,B.G.GRIMWOOD,T.H.PLUMMER JR.,T.CUI, REMARK 1 AUTH 2 C.GUAN,P.VAN ROEY REMARK 1 TITL CRYSTAL STRUCTURE OF GLYCOSYLASPARAGINASE FROM REMARK 1 TITL 2 FLAVOBACTERIUM MENINGOSEPTICUM REMARK 1 REF PROTEIN SCI. V. 7 774 1998 REMARK 1 REFN ISSN 0961-8368 REMARK 1 REFERENCE 4 REMARK 1 AUTH C.OINONEN,R.TIKKANEN,J.ROUVINEN,L.PELTONEN REMARK 1 TITL THREE-DIMENSIONAL STRUCTURE OF HUMAN LYSOSOMAL REMARK 1 TITL 2 ASPARTYLGLUCOSAMINIDASE REMARK 1 REF NAT.STRUCT.MOL.BIOL. V. 2 1102 1995 REMARK 1 REFN ISSN 1545-9993 REMARK 1 REFERENCE 5 REMARK 1 AUTH H.C.GUO,Q.XU,D.BUCKLEY,C.GUAN REMARK 1 TITL CRYSTAL STRUCTURES OF FLAVOBACTERIUM GLYCOSYLASPARAGINASE. REMARK 1 TITL 2 AN N-TERMINAL NUCLEOPHILE HYDROLASE ACTIVATED BY REMARK 1 TITL 3 INTRAMOLECULAR PROTEOLYSIS REMARK 1 REF J.BIOL.CHEM. V. 273 20205 1998 REMARK 1 REFN ISSN 0021-9258 REMARK 1 DOI 10.1074/JBC.273.32.20205 REMARK 1 REFERENCE 6 REMARK 1 AUTH Q.XU,D.BUCKLEY,C.GUAN,H.C.GUO REMARK 1 TITL STRUCTURAL INSIGHTS INTO THE MECHANISM OF INTRAMOLECULAR REMARK 1 TITL 2 PROTEOLYSIS REMARK 1 REF CELL(CAMBRIDGE,MASS.) V. 98 651 1999 REMARK 1 REFN ISSN 0092-8674 REMARK 1 DOI 10.1016/S0092-8674(00)80052-5
REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 3 NUMBER OF REFLECTIONS : 28994 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.170 REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1131 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4258 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 9 REMARK 3 SOLVENT ATOMS : 234 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.19 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.55000 REMARK 3 B22 (A**2) : -0.21000 REMARK 3 B33 (A**2) : -3.35000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.253 REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.013 ; 0.021 REMARK 3 ANGLE DISTANCE (A) : 0.024 ; 0.030 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.004 ; 0.020 REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.082 ; 0.200 REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.616 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.114 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.851 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.189 ; 4.500 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 TLS PARAMETERS WERE USED. IN EACH SUBUNIT, SEVERAL C-TERMINAL REMARK 3 RESIDUES WERE NOT MODELED DUE TO POOR REMARK 3 ELECTRON DENSITY (160-178 IN CHAIN A, 313-321 IN CHAIN B, 159-178 REMARK 3 IN CHAIN C, 314-321 IN CHAIN D). REMARK 3 IT IS POSSIBLE THAT (SOME OF) THE MISSING RESIDUES IN SUBUNITS REMARK 3 ALPHA (CHAINS A,C) ARE ABSENT BECAUSE REMARK 3 OF PROTEOLYTIC EXCISION OR DEGRADATION. REMARK 3 THE N-TERMINAL MET 1 RESIDUES OF SUBUNITS ALPHA (CHAINS A AND C) REMARK 3 ARE NOT REMARK 3 PRESENT IN THE MATURE PROTEIN.
REMARK 4 REMARK 4 1JN9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-AUG-01. REMARK 100 THE RCSB ID CODE IS RCSB013964.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-AUG-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97933 REMARK 200 MONOCHROMATOR : DOUBLE-CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : SBC-2 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29401 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.270 REMARK 200 RESOLUTION RANGE LOW (A) : 60.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.06400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 19.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.27 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.31 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.22200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: STRUCTURE OF A DIFFERENT CRYSTAL FORM AVAILABLE IN REMARK 200 THE LABORATORY REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: TRIS HCL PH 8.5, 0.2 M CALCIUM REMARK 280 CHLORIDE, PEG 4000, PEG 400, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 273K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 30.97050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.43100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.21250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 74.43100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.97050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.21250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE POLYPEPTIDE CHAIN ENCODED BY THE CDNA UNDERGOES REMARK 300 AUTOPROTEOLYTIC CLEAVAGE INTO TWO SUBUNITS, ALPHA AND BETA. THE REMARK 300 BIOLOGICAL ASSEMBLY IS A HETEROTETRAMER (OR A DIMER OF REMARK 300 HETERODIMERS) CONSISTING OF TWO SUBUNITS ALPHA AND TWO SUBUNITS REMARK 300 BETA, (ALPHA,BETA)2.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 15030 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -170.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 160 REMARK 465 ALA A 161 REMARK 465 THR A 162 REMARK 465 VAL A 163 REMARK 465 LEU A 164 REMARK 465 ASP A 165 REMARK 465 HIS A 166 REMARK 465 SER A 167 REMARK 465 GLY A 168 REMARK 465 ALA A 169 REMARK 465 PRO A 170 REMARK 465 LEU A 171 REMARK 465 ASP A 172 REMARK 465 GLU A 173 REMARK 465 LYS A 174 REMARK 465 GLN A 175 REMARK 465 LYS A 176 REMARK 465 MET A 177 REMARK 465 GLY A 178 REMARK 465 GLU B 313 REMARK 465 LYS B 314 REMARK 465 GLY B 315 REMARK 465 ASP B 316 REMARK 465 THR B 317 REMARK 465 VAL B 318 REMARK 465 ALA B 319 REMARK 465 THR B 320 REMARK 465 GLN B 321 REMARK 465 GLU C 159 REMARK 465 GLY C 160 REMARK 465 ALA C 161 REMARK 465 THR C 162 REMARK 465 VAL C 163 REMARK 465 LEU C 164 REMARK 465 ASP C 165 REMARK 465 HIS C 166 REMARK 465 SER C 167 REMARK 465 GLY C 168 REMARK 465 ALA C 169 REMARK 465 PRO C 170 REMARK 465 LEU C 171 REMARK 465 ASP C 172 REMARK 465 GLU C 173 REMARK 465 LYS C 174 REMARK 465 GLN C 175 REMARK 465 LYS C 176 REMARK 465 MET C 177 REMARK 465 GLY C 178 REMARK 465 LYS D 314 REMARK 465 GLY D 315 REMARK 465 ASP D 316 REMARK 465 THR D 317 REMARK 465 VAL D 318 REMARK 465 ALA D 319 REMARK 465 THR D 320 REMARK 465 GLN D 321
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 68 142.84 -171.87 REMARK 500 ALA B 216 -61.95 -100.46 REMARK 500 SER B 224 -79.93 -138.55 REMARK 500 ILE B 310 -52.67 -122.34 REMARK 500 LYS C 3 43.62 -89.53 REMARK 500 ALA D 216 -69.11 -101.01 REMARK 500 SER D 224 -70.92 -148.54 REMARK 500 MET D 295 119.61 -160.92 REMARK 500 ILE D 310 -53.57 -127.63 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 515 DISTANCE = 5.68 ANGSTROMS REMARK 525 HOH C 434 DISTANCE = 5.20 ANGSTROMS
REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 408 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 51 OD1 REMARK 620 2 ASP A 51 OD2 48.8 REMARK 620 3 HOH A 469 O 78.5 91.7 REMARK 620 4 HOH A 468 O 123.5 78.8 84.4 REMARK 620 5 HOH A 470 O 158.9 152.2 96.5 75.7 REMARK 620 6 HOH A 467 O 83.7 131.9 85.2 147.9 75.4 REMARK 620 7 GLU C 125 OE2 83.3 89.6 154.5 120.7 94.0 75.1 REMARK 620 8 GLU C 125 OE1 126.3 97.2 152.5 72.0 64.6 107.3 51.9 REMARK 620 N 1 2 3 4 5 6 7 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 401 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 LEU A 60 O REMARK 620 2 GLU A 61 O 79.7 REMARK 620 3 CME A 63 O 82.3 105.7 REMARK 620 4 PHE A 66 O 105.6 160.6 93.5 REMARK 620 5 ALA A 68 O 102.5 79.9 173.3 80.7 REMARK 620 6 ILE A 70 O 165.2 87.3 94.3 89.0 82.1 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 407 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 MET A 114 O REMARK 620 2 SER A 117 O 93.6 REMARK 620 3 HOH A 415 O 103.7 74.6 REMARK 620 4 HOH A 413 O 91.4 144.5 70.1 REMARK 620 5 HOH A 487 O 172.0 94.3 77.4 81.5 REMARK 620 6 HOH A 414 O 79.6 145.1 140.3 70.3 94.4 REMARK 620 7 HOH A 416 O 82.8 75.2 149.4 140.3 100.3 70.0 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B 409 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 304 OD1 REMARK 620 2 ASP B 304 OD2 47.1 REMARK 620 3 HOH B 453 O 69.1 75.6 REMARK 620 4 HOH B 454 O 101.0 84.2 159.0 REMARK 620 5 ASP D 188 O 147.7 155.2 92.3 104.2 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA C 402 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 LEU C 60 O REMARK 620 2 GLU C 61 O 78.0 REMARK 620 3 CME C 63 O 86.3 111.2 REMARK 620 4 PHE C 66 O 112.0 156.4 91.1 REMARK 620 5 ALA C 68 O 100.7 74.6 171.9 82.5 REMARK 620 6 ILE C 70 O 162.4 85.3 94.9 85.6 79.6 REMARK 620 N 1 2 3 4 5
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 407 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 408 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA B 409 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA C 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL C 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL D 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL D 406
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1APY RELATED DB: PDB REMARK 900 THREE-DIMENSIONAL STRUCTURE OF HUMAN LYSOSOMAL REMARK 900 ASPARTYLGLUCOSAMINIDASE. REMARK 900 RELATED ID: 1APZ RELATED DB: PDB REMARK 900 HUMAN ASPARTYLGLUCOSAMINIDASE COMPLEX WITH REACTION PRODUCT. REMARK 900 RELATED ID: 1AYY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GLYCOSYLASPARAGINASE FROM REMARK 900 FLAVOBACTERIUM MENINGOSEPTICUM. REMARK 900 RELATED ID: 2GAC RELATED DB: PDB REMARK 900 T152C MUTANT GLYCOSYLASPARAGINASE FROM FLAVOBACTERIUM REMARK 900 MENINGOSEPTICUM REMARK 900 RELATED ID: 2GAW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF FLAVOBACTERIUM GLYCOSYLASPARAGINASE. REMARK 900 RELATED ID: 9GAA RELATED DB: PDB REMARK 900 PRECURSOR OF THE T152A MUTANT GLYCOSYLASPARAGINASE FROM REMARK 900 FLAVOBACTERIUM MENINGOSEPTICUM REMARK 900 RELATED ID: 9GAC RELATED DB: PDB REMARK 900 PRECURSOR OF THE T152C MUTANT GLYCOSYLASPARAGINASE FROM REMARK 900 FLAVOBACTERIUM MENINGOSEPTICUM REMARK 900 RELATED ID: 9GAF RELATED DB: PDB REMARK 900 PRECURSOR OF THE W11F MUTANT GLYCOSYLASPARAGINASE FROM REMARK 900 FLAVOBACTERIUM MENINGOSEPTICUM
DBREF 1JN9 A 2 178 UNP P37595 ASGX_ECOLI 2 178 DBREF 1JN9 B 179 321 UNP P37595 ASGX_ECOLI 179 321 DBREF 1JN9 C 2 178 UNP P37595 ASGX_ECOLI 2 178 DBREF 1JN9 D 179 321 UNP P37595 ASGX_ECOLI 179 321
SEQADV 1JN9 CME A 63 UNP P37595 CYS 63 MODIFIED RESIDUE SEQADV 1JN9 CME C 63 UNP P37595 CYS 63 MODIFIED RESIDUE
SEQRES 1 A 177 GLY LYS ALA VAL ILE ALA ILE HIS GLY GLY ALA GLY ALA SEQRES 2 A 177 ILE SER ARG ALA GLN MET SER LEU GLN GLN GLU LEU ARG SEQRES 3 A 177 TYR ILE GLU ALA LEU SER ALA ILE VAL GLU THR GLY GLN SEQRES 4 A 177 LYS MET LEU GLU ALA GLY GLU SER ALA LEU ASP VAL VAL SEQRES 5 A 177 THR GLU ALA VAL ARG LEU LEU GLU GLU CME PRO LEU PHE SEQRES 6 A 177 ASN ALA GLY ILE GLY ALA VAL PHE THR ARG ASP GLU THR SEQRES 7 A 177 HIS GLU LEU ASP ALA CYS VAL MET ASP GLY ASN THR LEU SEQRES 8 A 177 LYS ALA GLY ALA VAL ALA GLY VAL SER HIS LEU ARG ASN SEQRES 9 A 177 PRO VAL LEU ALA ALA ARG LEU VAL MET GLU GLN SER PRO SEQRES 10 A 177 HIS VAL MET MET ILE GLY GLU GLY ALA GLU ASN PHE ALA SEQRES 11 A 177 PHE ALA ARG GLY MET GLU ARG VAL SER PRO GLU ILE PHE SEQRES 12 A 177 SER THR SER LEU ARG TYR GLU GLN LEU LEU ALA ALA ARG SEQRES 13 A 177 LYS GLU GLY ALA THR VAL LEU ASP HIS SER GLY ALA PRO SEQRES 14 A 177 LEU ASP GLU LYS GLN LYS MET GLY SEQRES 1 B 143 THR VAL GLY ALA VAL ALA LEU ASP LEU ASP GLY ASN LEU SEQRES 2 B 143 ALA ALA ALA THR SER THR GLY GLY MET THR ASN LYS LEU SEQRES 3 B 143 PRO GLY ARG VAL GLY ASP SER PRO LEU VAL GLY ALA GLY SEQRES 4 B 143 CYS TYR ALA ASN ASN ALA SER VAL ALA VAL SER CYS THR SEQRES 5 B 143 GLY THR GLY GLU VAL PHE ILE ARG ALA LEU ALA ALA TYR SEQRES 6 B 143 ASP ILE ALA ALA LEU MET ASP TYR GLY GLY LEU SER LEU SEQRES 7 B 143 ALA GLU ALA CYS GLU ARG VAL VAL MET GLU LYS LEU PRO SEQRES 8 B 143 ALA LEU GLY GLY SER GLY GLY LEU ILE ALA ILE ASP HIS SEQRES 9 B 143 GLU GLY ASN VAL ALA LEU PRO PHE ASN THR GLU GLY MET SEQRES 10 B 143 TYR ARG ALA TRP GLY TYR ALA GLY ASP THR PRO THR THR SEQRES 11 B 143 GLY ILE TYR ARG GLU LYS GLY ASP THR VAL ALA THR GLN SEQRES 1 C 177 GLY LYS ALA VAL ILE ALA ILE HIS GLY GLY ALA GLY ALA SEQRES 2 C 177 ILE SER ARG ALA GLN MET SER LEU GLN GLN GLU LEU ARG SEQRES 3 C 177 TYR ILE GLU ALA LEU SER ALA ILE VAL GLU THR GLY GLN SEQRES 4 C 177 LYS MET LEU GLU ALA GLY GLU SER ALA LEU ASP VAL VAL SEQRES 5 C 177 THR GLU ALA VAL ARG LEU LEU GLU GLU CME PRO LEU PHE SEQRES 6 C 177 ASN ALA GLY ILE GLY ALA VAL PHE THR ARG ASP GLU THR SEQRES 7 C 177 HIS GLU LEU ASP ALA CYS VAL MET ASP GLY ASN THR LEU SEQRES 8 C 177 LYS ALA GLY ALA VAL ALA GLY VAL SER HIS LEU ARG ASN SEQRES 9 C 177 PRO VAL LEU ALA ALA ARG LEU VAL MET GLU GLN SER PRO SEQRES 10 C 177 HIS VAL MET MET ILE GLY GLU GLY ALA GLU ASN PHE ALA SEQRES 11 C 177 PHE ALA ARG GLY MET GLU ARG VAL SER PRO GLU ILE PHE SEQRES 12 C 177 SER THR SER LEU ARG TYR GLU GLN LEU LEU ALA ALA ARG SEQRES 13 C 177 LYS GLU GLY ALA THR VAL LEU ASP HIS SER GLY ALA PRO SEQRES 14 C 177 LEU ASP GLU LYS GLN LYS MET GLY SEQRES 1 D 143 THR VAL GLY ALA VAL ALA LEU ASP LEU ASP GLY ASN LEU SEQRES 2 D 143 ALA ALA ALA THR SER THR GLY GLY MET THR ASN LYS LEU SEQRES 3 D 143 PRO GLY ARG VAL GLY ASP SER PRO LEU VAL GLY ALA GLY SEQRES 4 D 143 CYS TYR ALA ASN ASN ALA SER VAL ALA VAL SER CYS THR SEQRES 5 D 143 GLY THR GLY GLU VAL PHE ILE ARG ALA LEU ALA ALA TYR SEQRES 6 D 143 ASP ILE ALA ALA LEU MET ASP TYR GLY GLY LEU SER LEU SEQRES 7 D 143 ALA GLU ALA CYS GLU ARG VAL VAL MET GLU LYS LEU PRO SEQRES 8 D 143 ALA LEU GLY GLY SER GLY GLY LEU ILE ALA ILE ASP HIS SEQRES 9 D 143 GLU GLY ASN VAL ALA LEU PRO PHE ASN THR GLU GLY MET SEQRES 10 D 143 TYR ARG ALA TRP GLY TYR ALA GLY ASP THR PRO THR THR SEQRES 11 D 143 GLY ILE TYR ARG GLU LYS GLY ASP THR VAL ALA THR GLN
MODRES 1JN9 CME A 63 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 1JN9 CME C 63 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE
HET CME A 63 10 HET CME C 63 10 HET NA A 401 1 HET CL A 403 1 HET CA A 407 1 HET CA A 408 1 HET CA B 409 1 HET NA C 402 1 HET CL C 405 1 HET CL D 404 1 HET CL D 406 1
HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM NA SODIUM ION HETNAM CL CHLORIDE ION HETNAM CA CALCIUM ION
FORMUL 1 CME 2(C5 H11 N O3 S2) FORMUL 5 NA 2(NA 1+) FORMUL 6 CL 4(CL 1-) FORMUL 7 CA 3(CA 2+) FORMUL 14 HOH *234(H2 O)
HELIX 1 1 SER A 21 ALA A 45 1 25 HELIX 2 2 SER A 48 GLU A 62 1 15 HELIX 3 3 ASN A 105 SER A 117 1 13 HELIX 4 4 GLY A 124 ARG A 134 1 11 HELIX 5 5 SER A 140 SER A 145 5 6 HELIX 6 6 THR A 146 GLU A 159 1 14 HELIX 7 7 THR B 232 ALA B 239 1 8 HELIX 8 8 LEU B 240 TYR B 251 1 12 HELIX 9 9 SER B 255 GLU B 266 1 12 HELIX 10 10 GLU B 266 LEU B 271 1 6 HELIX 11 11 SER C 21 ALA C 45 1 25 HELIX 12 12 SER C 48 GLU C 62 1 15 HELIX 13 13 ASN C 105 SER C 117 1 13 HELIX 14 14 GLY C 124 ARG C 134 1 11 HELIX 15 15 SER C 140 SER C 145 5 6 HELIX 16 16 THR C 146 LYS C 158 1 13 HELIX 17 17 THR D 232 ALA D 239 1 8 HELIX 18 18 LEU D 240 TYR D 251 1 12 HELIX 19 19 SER D 255 GLU D 266 1 12 HELIX 20 20 GLU D 266 LEU D 271 1 6
SHEET 1 A 9 THR B 307 TYR B 311 0 SHEET 2 A 9 GLY B 294 TYR B 301 -1 N MET B 295 O ILE B 310 SHEET 3 A 9 VAL A 5 GLY A 13 -1 N ILE A 6 O GLY B 300 SHEET 4 A 9 VAL B 180 LEU B 185 -1 N GLY B 181 O HIS A 9 SHEET 5 A 9 LEU B 191 THR B 197 -1 O ALA B 192 N ALA B 184 SHEET 6 A 9 LEU A 82 ASP A 88 -1 O ASP A 83 N THR B 197 SHEET 7 A 9 LYS A 93 VAL A 100 -1 O LYS A 93 N ASP A 88 SHEET 8 A 9 MET A 121 ILE A 123 1 N MET A 122 O ALA A 96 SHEET 9 A 9 ARG D 207 VAL D 208 -1 N VAL D 208 O MET A 121 SHEET 1 B 9 ARG B 207 VAL B 208 0 SHEET 2 B 9 MET C 121 ILE C 123 -1 O MET C 121 N VAL B 208 SHEET 3 B 9 LYS C 93 VAL C 100 1 O ALA C 96 N MET C 122 SHEET 4 B 9 LEU C 82 ASP C 88 -1 O LEU C 82 N VAL C 100 SHEET 5 B 9 LEU D 191 THR D 197 -1 O ALA D 193 N MET C 87 SHEET 6 B 9 VAL D 180 LEU D 185 -1 N VAL D 180 O SER D 196 SHEET 7 B 9 VAL C 5 GLY C 13 -1 O VAL C 5 N LEU D 185 SHEET 8 B 9 GLY D 294 TYR D 301 -1 O GLY D 294 N GLY C 13 SHEET 9 B 9 THR D 307 GLY D 309 -1 N THR D 307 O TRP D 299 SHEET 1 C 4 CYS B 218 ALA B 220 0 SHEET 2 C 4 VAL B 225 GLY B 231 -1 N VAL B 227 O TYR B 219 SHEET 3 C 4 GLY B 275 ASP B 281 -1 N GLY B 276 O THR B 230 SHEET 4 C 4 VAL B 286 ALA B 287 -1 N ALA B 287 O ALA B 279 SHEET 1 D 4 CYS D 218 ALA D 220 0 SHEET 2 D 4 VAL D 225 GLY D 231 -1 N VAL D 227 O TYR D 219 SHEET 3 D 4 GLY D 275 ASP D 281 -1 N GLY D 276 O THR D 230 SHEET 4 D 4 VAL D 286 ALA D 287 -1 N ALA D 287 O ALA D 279
LINK C GLU A 62 N CME A 63 1555 1555 1.26 LINK C CME A 63 N PRO A 64 1555 1555 1.35 LINK C GLU C 62 N CME C 63 1555 1555 1.21 LINK C CME C 63 N PRO C 64 1555 1555 1.28 LINK OD1 ASP A 51 CA CA A 408 1555 1555 2.76 LINK OD2 ASP A 51 CA CA A 408 1555 1555 2.32 LINK O LEU A 60 NA NA A 401 1555 1555 2.75 LINK O GLU A 61 NA NA A 401 1555 1555 2.48 LINK O CME A 63 NA NA A 401 1555 1555 2.24 LINK O PHE A 66 NA NA A 401 1555 1555 2.69 LINK O ALA A 68 NA NA A 401 1555 1555 2.25 LINK O ILE A 70 NA NA A 401 1555 1555 2.24 LINK O MET A 114 CA CA A 407 1555 1555 2.43 LINK O SER A 117 CA CA A 407 1555 1555 2.33 LINK OD1 ASP B 304 CA CA B 409 1555 1555 2.55 LINK OD2 ASP B 304 CA CA B 409 1555 1555 2.84 LINK O LEU C 60 NA NA C 402 1555 1555 2.64 LINK O GLU C 61 NA NA C 402 1555 1555 2.43 LINK O CME C 63 NA NA C 402 1555 1555 2.27 LINK O PHE C 66 NA NA C 402 1555 1555 2.62 LINK O ALA C 68 NA NA C 402 1555 1555 2.48 LINK O ILE C 70 NA NA C 402 1555 1555 2.23 LINK CA CA A 407 O HOH A 415 1555 1555 2.34 LINK CA CA A 407 O HOH A 413 1555 1555 2.47 LINK CA CA A 407 O HOH A 487 1555 1555 2.23 LINK CA CA A 407 O HOH A 414 1555 1555 2.30 LINK CA CA A 407 O HOH A 416 1555 1555 2.36 LINK CA CA A 408 O HOH A 469 1555 1555 2.27 LINK CA CA A 408 O HOH A 468 1555 1555 2.29 LINK CA CA A 408 O HOH A 470 1555 1555 2.08 LINK CA CA A 408 O HOH A 467 1555 1555 2.38 LINK CA CA B 409 O HOH B 453 1555 1555 2.29 LINK CA CA B 409 O HOH B 454 1555 1555 2.50 LINK CA CA A 408 OE2 GLU C 125 1555 3545 2.44 LINK CA CA A 408 OE1 GLU C 125 1555 3545 2.58 LINK CA CA B 409 O ASP D 188 1555 3645 2.24
SITE 1 AC1 6 LEU A 60 GLU A 61 CME A 63 PHE A 66 SITE 2 AC1 6 ALA A 68 ILE A 70 SITE 1 AC2 3 GLN A 23 ILE D 310 TYR D 311 SITE 1 AC3 7 MET A 114 SER A 117 HOH A 413 HOH A 414 SITE 2 AC3 7 HOH A 415 HOH A 416 HOH A 487 SITE 1 AC4 6 ASP A 51 HOH A 467 HOH A 468 HOH A 469 SITE 2 AC4 6 HOH A 470 GLU C 125 SITE 1 AC5 4 ASP B 304 HOH B 453 HOH B 454 ASP D 188 SITE 1 AC6 6 LEU C 60 GLU C 61 CME C 63 PHE C 66 SITE 2 AC6 6 ALA C 68 ILE C 70 SITE 1 AC7 3 ILE B 310 TYR B 311 LEU C 22 SITE 1 AC8 3 ALA C 14 THR D 292 GLU D 293 SITE 1 AC9 2 ARG D 262 LYS D 267
CRYST1 61.941 70.425 148.862 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.016144 0.000000 0.000000 0.00000
SCALE2 0.000000 0.014200 0.000000 0.00000
SCALE3 0.000000 0.000000 0.006718 0.00000